MDCalc
Tool
For professionals
An online CDAI calculator. It shows that the CDAI needs a 7-day symptom diary, body weight and a blood test result, and explains that a score under 150 is a marker of remission and over 450 a marker of severe Crohn's.
Topics
Monitoring
Research
Jargon explained
Crohn's Disease Activity Index
haematocrit
remission
Gastroenterology
Study
Mar 2007
Patients and professionals
The key trial of infliximab in 112 children with moderate to severe Crohn's. After the first three doses, 88% had improved and 59% were in remission. Children given the drug every 8 weeks afterwards did better at one year than those given it every 12 weeks. It led to infliximab being used for children.
Topics
Children and young people
Biologics and newer medicines
Jargon explained
induction
maintenance
clinical response
PCDAI
Gastroenterology
Study
Jan 2007
Patients and professionals
The main trial behind adalimumab (Humira and its biosimilars) for keeping Crohn's under control. People who improved on adalimumab were much more likely to still be in remission at about a year if they kept taking it (36-41%) than if switched to placebo (12%). Taking it weekly worked no better than every other week.
Topics
Biologics and newer medicines
Jargon explained
maintenance
remission
CDAI
placebo
MDCalc
Tool
For professionals
An online calculator used by clinicians for the Harvey-Bradshaw Index. It explains how scores are read: under 5 is remission, 5 to 7 mild, 8 to 16 moderate and above that severe.
Topics
Monitoring
Jargon explained
Harvey-Bradshaw Index
remission
New Zealand Society of Gastroenterology
Leaflet
For patients
A patient leaflet that walks through scoring your own Harvey-Bradshaw Index based on how you were yesterday: general wellbeing, tummy pain, number of loose poos, any lump in the tummy, and points for complications such as joint, eye, mouth, skin or bottom problems. The points are added up for a total score to share with your IBD team.
Topics
Monitoring
Flare-ups
Jargon explained
Harvey-Bradshaw Index
abdominal mass
fistula
uveitis
erythema nodosum
NICE CKS
Guide
May 2024
For professionals
Lists the tests a GP may arrange when Crohn's is suspected: a full blood count, inflammation markers (CRP and ESR), kidney and liver tests including albumin, iron, B12, folate and vitamin D levels, a coeliac blood test, poo samples to rule out infection, and faecal calprotectin in adults. It notes that these results can be normal even when Crohn's is active, so normal results do not rule it out.
Topics
Diagnosis and tests
Jargon explained
full blood count
C-reactive protein
erythrocyte sedimentation rate
albumin
faecal calprotectin
coeliac disease
stool culture
NICE
Guideline
Oct 2013
For professionals
NICE guidance recommending the faecal calprotectin poo test to help tell inflammatory bowel disease apart from non-inflammatory conditions such as IBS.
Topics
Diagnosis and tests
Monitoring
Jargon explained
faecal calprotectin
irritable bowel syndrome
Northern Lincolnshire and Goole NHS Foundation Trust
Leaflet
Dec 2025
For patients
A hospital leaflet explaining the calprotectin poo test, which shows whether there is inflammation in the gut and is used both to help diagnose and to monitor conditions such as IBD. It explains how to collect the sample and warns that anti-inflammatory painkillers such as ibuprofen can affect the result, so ask your doctor before stopping or continuing them.
Topics
Diagnosis and tests
Monitoring
Jargon explained
faecal calprotectin
NSAIDs
The Lancet
Study
Dec 2017
Patients and professionals
CALM compared deciding treatment on symptoms alone with 'tight control', where treatment was stepped up if blood or poo tests (CRP and faecal calprotectin) showed inflammation even when people felt fine. After 48 weeks, 46% in the tight control group had a healed bowel lining compared with 30% in the symptom-only group. It is a cornerstone of the 'treat to target' approach.
Topics
Monitoring
Biologics and newer medicines
Research
Jargon explained
tight control
faecal calprotectin
CRP
mucosal healing
treat to target
Gut (BMJ) via PubMed Central
Study
Jul 2014
For professionals
UK researchers built a short questionnaire, with input from patients, that asks people with IBD how well controlled their condition has felt over the past two weeks. It has 13 yes/no/not sure questions plus a 0-100 scale and took about a minute to complete. In nearly 300 patients it gave consistent results and tracked well with doctors' own activity scores.
Topics
Monitoring
Flare-ups
Jargon explained
patient reported outcome measure
visual analogue scale
validation
Porto Biomedical Journal via PubMed Central
Study
Jul 2024
For professionals
A study of 196 people with Crohn's affecting only the small bowel, comparing calprotectin levels with capsule endoscopy findings. Calprotectin matched the camera findings only moderately and no cut-off was reliable enough on its own, supporting the point that a normal calprotectin does not rule out small bowel inflammation.
Topics
Diagnosis and tests
Monitoring
Jargon explained
faecal calprotectin
capsule endoscopy
small bowel
Frontiers in Medicine (PubMed Central)
Systematic review
2025
For professionals
A 2025 open-access analysis comparing types of psychological therapy for people with IBD. Mindfulness and CBT reduced depression, acceptance and commitment therapy and CBT reduced anxiety, and CBT ranked well for stress. The authors see these therapies as useful additions to medical care, with uncertain effects on disease activity.
Topics
Mental health
Research
Jargon explained
cognitive behavioural therapy
mindfulness
acceptance and commitment therapy
network meta-analysis